Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

2266

Actual shortage: 50 (2%)
Anticipated shortage: 0 (0%)
Avoided shortage: 19 (1%)
Resolved: 2197 (97%)

Discontinuation Reports

124

To be discontinued: 4 (3%)
Discontinued: 118 (95%)
Reversed: 2 (2%)

Late reports

451 (19%)

Overdue reports

13 (24%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ SOLIFENACIN 10MG TABLET Resolved 2023-08-14 2023-10-24 201755
SANDOZ SOLIFENACIN 5MG TABLET Resolved 2023-09-19 2023-10-17 204748
SANDOZ SOLIFENACIN 5MG TABLET Resolved 2024-01-23 2024-02-06 217056
SANDOZ SOLIFENACIN 5MG TABLET Resolved 2024-05-21 2024-06-18 228426
SANDOZ SOLIFENACIN 5MG TABLET Resolved 2025-10-06 2025-10-14 268608
SANDOZ SUMATRIPTAN 100MG TABLET Resolved 2017-03-14 2017-05-15 2654
SANDOZ SUNITINIB 12.5MG CAPSULE Resolved 2025-02-03 2025-02-17 249423
SANDOZ SUNITINIB 25MG CAPSULE Resolved 2025-02-03 2025-02-17 249426
SANDOZ SUNITINIB 50MG CAPSULE Resolved 2025-02-03 2025-02-17 249429
SANDOZ TACROLIMUS 0.5MG CAPSULE (IMMEDIATE RELEASE) Resolved 2023-10-23 2023-10-31 207776
SANDOZ TACROLIMUS 1MG CAPSULE (IMMEDIATE RELEASE) Resolved 2025-11-17 2025-12-01 272003
SANDOZ TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Resolved 2017-09-07 2017-11-27 21350
SANDOZ TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Resolved 2021-12-30 2022-01-12 151967
SANDOZ TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Resolved 2023-06-28 2025-05-21 196790
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-09-07 2017-10-28 21343
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-09-07 2017-10-28 21347
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2021-06-28 2021-07-05 141597
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2021-08-09 2021-08-16 143869
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2021-10-04 2021-10-20 146655
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-28 2022-12-11 176003

Showing 1901 to 1920 of 2266

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000

Showing 1 to 20 of 124